Review of low-grade gliomas in children—evolving molecular era and therapeutic insights

Soumen Khatua, Jason Wang, Veena Rajaram

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Low-grade gliomas are the commonest brain tumor in children comprising heterogeneous pathological entities. Though the overall prognosis is good, unresectable, and recurrent or progressive tumors in eloquent areas of the brain remain major therapeutic challenge even with advances in chemotherapeutic strategies. With the evolving surge of molecular data, improved understanding of the biology of these tumors is now perceivable that could provide insights into novel therapies. We hope the new era will enable us to profile comprehensive histopathological/molecular classification and prognostic molecular markers in these tumors and guide us to tailor optimal targeted therapy.

Original languageEnglish (US)
Pages (from-to)643-652
Number of pages10
JournalChild's Nervous System
Volume31
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Glioma
Tumor Biomarkers
Brain Neoplasms
Neoplasms
Therapeutics
Brain

Keywords

  • Histopathology
  • Low-grade gliomas
  • Molecular biology
  • Therapeutic insights

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Review of low-grade gliomas in children—evolving molecular era and therapeutic insights. / Khatua, Soumen; Wang, Jason; Rajaram, Veena.

In: Child's Nervous System, Vol. 31, No. 5, 01.05.2015, p. 643-652.

Research output: Contribution to journalArticle

@article{df5376da2f9c4e7883abc5af1f850897,
title = "Review of low-grade gliomas in children—evolving molecular era and therapeutic insights",
abstract = "Low-grade gliomas are the commonest brain tumor in children comprising heterogeneous pathological entities. Though the overall prognosis is good, unresectable, and recurrent or progressive tumors in eloquent areas of the brain remain major therapeutic challenge even with advances in chemotherapeutic strategies. With the evolving surge of molecular data, improved understanding of the biology of these tumors is now perceivable that could provide insights into novel therapies. We hope the new era will enable us to profile comprehensive histopathological/molecular classification and prognostic molecular markers in these tumors and guide us to tailor optimal targeted therapy.",
keywords = "Histopathology, Low-grade gliomas, Molecular biology, Therapeutic insights",
author = "Soumen Khatua and Jason Wang and Veena Rajaram",
year = "2015",
month = "5",
day = "1",
doi = "10.1007/s00381-015-2653-2",
language = "English (US)",
volume = "31",
pages = "643--652",
journal = "Child's Nervous System",
issn = "0256-7040",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Review of low-grade gliomas in children—evolving molecular era and therapeutic insights

AU - Khatua, Soumen

AU - Wang, Jason

AU - Rajaram, Veena

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Low-grade gliomas are the commonest brain tumor in children comprising heterogeneous pathological entities. Though the overall prognosis is good, unresectable, and recurrent or progressive tumors in eloquent areas of the brain remain major therapeutic challenge even with advances in chemotherapeutic strategies. With the evolving surge of molecular data, improved understanding of the biology of these tumors is now perceivable that could provide insights into novel therapies. We hope the new era will enable us to profile comprehensive histopathological/molecular classification and prognostic molecular markers in these tumors and guide us to tailor optimal targeted therapy.

AB - Low-grade gliomas are the commonest brain tumor in children comprising heterogeneous pathological entities. Though the overall prognosis is good, unresectable, and recurrent or progressive tumors in eloquent areas of the brain remain major therapeutic challenge even with advances in chemotherapeutic strategies. With the evolving surge of molecular data, improved understanding of the biology of these tumors is now perceivable that could provide insights into novel therapies. We hope the new era will enable us to profile comprehensive histopathological/molecular classification and prognostic molecular markers in these tumors and guide us to tailor optimal targeted therapy.

KW - Histopathology

KW - Low-grade gliomas

KW - Molecular biology

KW - Therapeutic insights

UR - http://www.scopus.com/inward/record.url?scp=84939962061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939962061&partnerID=8YFLogxK

U2 - 10.1007/s00381-015-2653-2

DO - 10.1007/s00381-015-2653-2

M3 - Article

C2 - 25722047

AN - SCOPUS:84939962061

VL - 31

SP - 643

EP - 652

JO - Child's Nervous System

JF - Child's Nervous System

SN - 0256-7040

IS - 5

ER -